Welcome to our dedicated page for Know Labs news (Ticker: USBC), a resource for investors and traders seeking the latest updates and insights on Know Labs stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Know Labs's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Know Labs's position in the market.
USBC (NYSE American: USBC), formerly known as Know Labs, has completed its corporate rebranding following a significant strategic acquisition. The company announced the successful implementation of its new name and ticker symbol change, effective August 15, 2025.
This transformation follows the $125 million strategic acquisition of a controlling interest by Goldeneye 1995 LLC, completed on August 6, 2025. The acquisition was led by Greg Kidd, who has been appointed as the Company's new Chairman and CEO. The rebranding aligns with the company's new strategic focus on the USBC deposit token.
FAQ
What is the current stock price of Know Labs (USBC)?
